Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection - PubMed (original) (raw)
doi: 10.1038/mi.2010.14. Epub 2010 Mar 31.
L D Harris, C L Vinton, H Sung, J A Briant, B Tabb, D Morcock, J W McGinty, J D Lifson, B A Lafont, M A Martin, A D Levine, J D Estes, J M Brenchley
Affiliations
- PMID: 20357762
- PMCID: PMC2891168
- DOI: 10.1038/mi.2010.14
Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection
N R Klatt et al. Mucosal Immunol. 2010 Jul.
Abstract
Pigtail macaques (PTMs) rapidly progress to AIDS after simian immunodeficiency virus (SIV) infection. Given the strong association between human immunodeficiency virus (HIV) and SIV disease progression and microbial translocation and immune activation, we assessed whether high basal levels of immune activation and microbial translocation exist in PTMs. We found that before SIV infection, PTMs had high levels of microbial translocation that correlated with significant damage to the structural barrier of the gastrointestinal tract. Moreover, this increased microbial translocation correlated with high levels of immune activation and was associated with high frequencies of interleukin-17-producing T cells. These data highlight the relationship among mucosal damage, microbial translocation and systemic immune activation in the absence of SIV replication, and underscore the importance of microbial translocation in the rapid course of disease progression in SIV-infected PTMs. Furthermore, these data suggest that PTM may be an ideal model to study therapeutic interventions aimed at decreasing microbial translocation-induced immune activation.
Conflict of interest statement
Disclosure: The authors declare no conflicts of interest.
Figures
Figure 1. Uninfected pigtail macaques have high levels of immune activation and memory-effector T cells compared to rhesus macaques and humans
(a) Frequencies of CD4+Ki67+ T cells in blood, (b) Frequencies of CD8+Ki67+ T cells in blood, (c) Frequencies of CD4+ memory-effector T cells in blood and necropsy tissues, (d) Frequencies of CD8+ memory-effector T cells in blood and necropsy tissues. PTM (circles), RM (triangles). Memory-effector T cells were determined by gating on both CD28+C95+ and CD28- subsets as measured by flow cytometry. Horizontal bars indicate median. P values calculated from Mann-Whitney U test.
Figure 2. Uninfected pigtail macaques have high frequencies of CD4+CCR5+T cells compared to rhesus macaques
Frequencies of CD4+CCR5+ T cells in blood and necropsy tissues. PTM (circles), RM (triangles). Horizontal bars indicate median. P values from Mann-Whitney U test.
Figure 3. High frequencies of T cells from uninfected pigtail macaques produce IL-17 compared to rhesus macaques
(a) Frequencies of CD4+ IFNγ producing T cells in blood, (b) Frequencies of CD8+ IFNγ producing T cells in blood, (c) Frequencies of CD4+ IL-17 producing T cells in blood and necropsy tissues, (d) Frequencies of CD8+ IL-17 producing T cells in blood and necropsy tissues, (e) Frequencies of CD4+ vs. CD8+ IL-17 producing T cells in blood of PTM. Correlation (r) determined by Spearman's rank correlation. All samples were stimulated with PMA and Ionomycin. PTM (circles) and RM (triangles). Horizontal bars indicate median. P values from Mann-Whitney U test.
Figure 4. Plasma LPS and Lactulose to Mannitol ratio indicate microbial translocation and gut permeability in uninfected pigtail macaques
(a) Plasma LPS levels. (b) Lactulose to manitol ratio. PTM (circles), RM (triangles), humans (squares). Horizontal bars indicate median. P values from Mann-Whitney U test.
Figure 5. Uninfected pigtail macaques have increased damage to the tight epithelial barrier and high levels of LPS in the lamina propria of the colon
(a) Representative claudin-3 staining (brown) in colon of PTM, (b) Representative claudin-3 staining (brown) in colon of RM, (c) Ratio of measurements of breached epithelial (no claudin) to intact epithelial (claudin) in either PTM and RM, (d) Representative LPS staining (brown) in colon of PTM, (e) Representative LPS staining (brown) in colon of RM, (f) Area of colon lamina propria LPS measured in PTM and RM. PTM (circles), RM (triangles). Horizontal bars indicate median. P values from Mann-Whitney U test.
Figure 6. Breaches in the colon correlates with microbial translocation, and microbial translocation correlates with immune activation in the colon of uninfected pigtail macaques
(a) The breach/intact ratio of the colon as measured by claudin significantly correlates with the amount of microbial tranlsocation into the lamina propria of the colon of PTM (b) The amount of MxA (a specific type I IFN responsive gene) in the colon as measured by IHC staining significantly correlates with the amount of microbial translocation into the colon of PTM. Correlations determined by Spearman's rank correlation. Lines indicate linear regression.
Figure 7. Local microbial translocation and immune activation in the colon results in systemic microbial translocation and immune activation in uninfected pigtail macaques
(a) The amount of LPS measured in the colon significantly correlates with LPS in the mesenteric LN. (b) The amount of MxA in the colon significantly correlates with the amount of MxA in the mesenteric LN. (c) LPS in the mesenteric LN significantly correlates with LPS in the axillary LN. (d) MxA in the mesenteric LN significantly correlates with MxA in the axillary LN. (e) LPS in the colon is associated with sCD14 in plasma, (f) MxA in the colon significantly correlates with sCD14 in plasma. Correlations determined by Spearman's rank correlation. Lines indicate linear regression.
Similar articles
- Rate of AIDS progression is associated with gastrointestinal dysfunction in simian immunodeficiency virus-infected pigtail macaques.
Canary LA, Vinton CL, Morcock DR, Pierce JB, Estes JD, Brenchley JM, Klatt NR. Canary LA, et al. J Immunol. 2013 Mar 15;190(6):2959-65. doi: 10.4049/jimmunol.1202319. Epub 2013 Feb 11. J Immunol. 2013. PMID: 23401593 Free PMC article. - Elite Control, Gut CD4 T Cell Sparing, and Enhanced Mucosal T Cell Responses in Macaca nemestrina Infected by a Simian Immunodeficiency Virus Lacking a gp41 Trafficking Motif.
Breed MW, Elser SE, Torben W, Jordan AP, Aye PP, Midkiff C, Schiro F, Sugimoto C, Alvarez-Hernandez X, Blair RV, Somasunderam A, Utay NS, Kuroda MJ, Pahar B, Wiseman RW, O'Connor DH, LaBranche CC, Montefiori DC, Marsh M, Li Y, Piatak M Jr, Lifson JD, Keele BF, Fultz PN, Lackner AA, Hoxie JA. Breed MW, et al. J Virol. 2015 Oct;89(20):10156-75. doi: 10.1128/JVI.01134-15. Epub 2015 Jul 29. J Virol. 2015. PMID: 26223646 Free PMC article. - Microbial translocation in the pathogenesis of HIV infection and AIDS.
Marchetti G, Tincati C, Silvestri G. Marchetti G, et al. Clin Microbiol Rev. 2013 Jan;26(1):2-18. doi: 10.1128/CMR.00050-12. Clin Microbiol Rev. 2013. PMID: 23297256 Free PMC article. Review. - Th17 cells in pathogenic simian immunodeficiency virus infection of macaques.
Cecchinato V, Franchini G. Cecchinato V, et al. Curr Opin HIV AIDS. 2010 Mar;5(2):141-5. doi: 10.1097/COH.0b013e32833653ec. Curr Opin HIV AIDS. 2010. PMID: 20543591 Free PMC article. Review.
Cited by
- The Impact of SIV-Induced Immunodeficiency on SARS-CoV-2 Disease, Viral Dynamics, and Antiviral Immune Response in a Nonhuman Primate Model of Coinfection.
Melton A, Rowe LA, Penney T, Krzykwa C, Goff K, Scheuermann SE, Melton HJ, Williams K, Golden N, Green KM, Smith B, Russell-Lodrigue K, Dufour JP, Doyle-Meyers LA, Schiro F, Aye PP, Lifson JD, Beddingfield BJ, Blair RV, Bohm RP, Kolls JK, Rappaport J, Hoxie JA, Maness NJ. Melton A, et al. Viruses. 2024 Jul 21;16(7):1173. doi: 10.3390/v16071173. Viruses. 2024. PMID: 39066335 Free PMC article. - SIV infection and ARV treatment reshape the transcriptional and epigenetic profile of naïve and memory T cells in vivo.
Rahmberg AR, Markowitz TE, Mudd JC, Ortiz AM, Brenchley JM. Rahmberg AR, et al. J Virol. 2024 Jun 13;98(6):e0028324. doi: 10.1128/jvi.00283-24. Epub 2024 May 23. J Virol. 2024. PMID: 38780248 - Maintenance of caecal homeostasis by diverse adaptive immune cells in the rhesus macaque.
Castro Dopico X, Guryleva M, Mandolesi M, Corcoran M, Coquet JM, Murrell B, Karlsson Hedestam GB. Castro Dopico X, et al. Clin Transl Immunology. 2024 May 2;13(5):e1508. doi: 10.1002/cti2.1508. eCollection 2024. Clin Transl Immunology. 2024. PMID: 38707998 Free PMC article. - Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies.
Mudd JC. Mudd JC. Viruses. 2024 Mar 27;16(4):514. doi: 10.3390/v16040514. Viruses. 2024. PMID: 38675857 Free PMC article. Review. - The Impact of SIV-Induced Immunodeficiency on Clinical Manifestation, Immune Response, and Viral Dynamics in SARS-CoV-2 Coinfection.
Melton A, Rowe LA, Penney T, Krzykwa C, Goff K, Scheuermann S, Melton HJ, Williams K, Golden N, Green KM, Smith B, Russell-Lodrigue K, Dufour JP, Doyle-Meyers LA, Schiro F, Aye PP, Lifson JD, Beddingfield BJ, Blair RV, Bohm RP, Kolls JK, Rappaport J, Hoxie JA, Maness NJ. Melton A, et al. bioRxiv [Preprint]. 2023 Nov 16:2023.11.15.567132. doi: 10.1101/2023.11.15.567132. bioRxiv. 2023. PMID: 38014096 Free PMC article. Updated. Preprint.
References
- Boirivant M, Amendola A, Butera A. Intestinal microflora and immunoregulation. Mucosal Immunol. 2008;1(1):S47–49. - PubMed
- Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009;9:799–809. - PubMed
- Baumgart DC, Dignass AU. Intestinal barrier function. Current Opinion in Clinical Nutrition & Metabolic Care. 2002;5:685–694. - PubMed
- Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem. 2003;278:1910–1914. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- Z99 AI999999/ImNIH/Intramural NIH HHS/United States
- HHMI/Howard Hughes Medical Institute/United States
- HHSN261200800001C/CA/NCI NIH HHS/United States
- HHSN261200800001E/CA/NCI NIH HHS/United States
- P01 AI076174/AI/NIAID NIH HHS/United States
- ZIA AI001029-02/ImNIH/Intramural NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous